{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T04:21:50Z","timestamp":1692332510491},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>For patients with a known hereditary risk of ovarian cancer, primary prevention typically is accomplished through prophylactic bilateral salpingo-oophorectomy. However, some patients may wish to preserve fertility or delay menopause and its associated comorbidities. This article discusses appropriate methods of contraception for these patients.<\/jats:p>","DOI":"10.1097\/01.jaa.0000586384.47435.31","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T20:35:11Z","timestamp":1572899711000},"page":"37-41","source":"Crossref","is-referenced-by-count":0,"title":["Contraception options for patients with known hereditary risk for ovarian cancer"],"prefix":"10.1097","volume":"32","author":[{"given":"Kelly M.","family":"Joy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1","key":"R3-20230817","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.critrevonc.2008.06.003","article-title":"Hereditary ovarian cancer","volume":"69","author":"Russo","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"R4-20230817","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10897-017-0089-4","article-title":"Information mismatch: cancer risk counseling with diverse underserved patients","volume":"26","author":"Joseph","year":"2017","journal-title":"J Genet Couns"},{"issue":"1","key":"R5-20230817","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10689-007-9144-x","article-title":"Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis","volume":"7","author":"Lu","year":"2008","journal-title":"Fam Cancer"},{"key":"R6-20230817","first-page":"1","article-title":"Lynch syndrome","author":"Kohlman","year":"2018","journal-title":"GeneReviews"},{"key":"R7-20230817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cogc.2014.12.006","article-title":"Review: genetic cancer ovary","author":"Osman","year":"2014","journal-title":"Clin Ovarian Other Gynecol Cancer"},{"issue":"11","key":"R8-20230817","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/00016340802443806","article-title":"Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families","volume":"87","author":"Boilesen","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"R9-20230817","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian carcinoma","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"R10-20230817","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"R11-20230817","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"R12-20230817","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molonc.2009.02.004","article-title":"Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management","volume":"3","author":"Lynch","year":"2009","journal-title":"Mol Oncol"},{"issue":"2","key":"R13-20230817","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"issue":"Pt 20","key":"R14-20230817","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1242\/jcs.114.20.3591","article-title":"Functions of BRCA1 and BRCA2 in the biological response to DNA damage","volume":"114","author":"Venkitaraman","year":"2001","journal-title":"J Cell Sci"},{"issue":"11","key":"R16-20230817","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"R17-20230817","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"R18-20230817","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"issue":"3","key":"R19-20230817","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"1","key":"R20-20230817","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"Mavaddat","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"R21-20230817","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"R22-20230817","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"R23-20230817","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"issue":"22","key":"R24-20230817","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"7186","key":"R25-20230817","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.318.7186.786","article-title":"Forth nightly review: hereditary ovarian carcinoma","volume":"318","author":"Kasprzak","year":"1999","journal-title":"BMJ"},{"issue":"10 suppl","key":"R26-20230817","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/cncr.11345","article-title":"Pathology and classification of ovarian tumors","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer"},{"issue":"7716","key":"R27-20230817","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"R28-20230817","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-0-387-69080-3_16","article-title":"Ovulation and ovarian cancer","volume":"617","author":"Hillier","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"R29-20230817","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/153.9.860","article-title":"Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer","volume":"153","author":"Purdie","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"6","key":"R30-20230817","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1055-9965.EPI-07-0089","article-title":"Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study","volume":"16","author":"Soegaard","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"R31-20230817","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ijc.29386","article-title":"Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers","volume":"137","author":"Kotsopoulos","year":"2015","journal-title":"Int J Cancer"},{"issue":"6","key":"R32-20230817","doi-asserted-by":"crossref","first-page":"dju091","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"25","key":"R33-20230817","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"issue":"22","key":"R34-20230817","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"issue":"5","key":"R35-20230817","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/ijc.29471","article-title":"Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: results from the EPIC cohort","volume":"137","author":"Fortner","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"R36-20230817","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10552-017-0868-0","article-title":"Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future","volume":"28","author":"Webb","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"2","key":"R37-20230817","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.cej.0000179274.24200.9d","article-title":"Oral contraceptives and ovarian cancer: an update, 1998-2004","volume":"15","author":"Vecchia","year":"2006","journal-title":"Eur J Cancer Prev"},{"issue":"9","key":"R38-20230817","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/IGC.0000000000000540","article-title":"Oral contraceptive use and reproductive characteristics affect survival in patients with epithelial ovarian cancer: a cohort study","volume":"25","author":"Kolomeyevskaya","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"33","key":"R39-20230817","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"R40-20230817","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol"},{"issue":"6","key":"R41-20230817","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"R42-20230817","first-page":"CD002126","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"R43-20230817","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/0284186X.2016.1175660","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol"},{"issue":"6","key":"R44-20230817","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"R45-20230817","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2014.03.041","article-title":"Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies","volume":"102","author":"Rice","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"R46-20230817","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"6","key":"R47-20230817","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1600-0412.2011.01114.x","article-title":"Underlying mechanisms of ovarian cancer risk reduction after tubal ligation","volume":"90","author":"Cibula","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"R48-20230817","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2016.09.004","article-title":"Tubal contraception and ovarian cancer risk: a global view","volume":"95","author":"Callahan","year":"2017","journal-title":"Contraception"},{"issue":"7","key":"R50-20230817","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1158\/1055-9965.EPI-09-0024","article-title":"Oral contraceptive use and BRCA penetrance: a case-only study","volume":"18","author":"Pasanisi","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"R51-20230817","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.11167","article-title":"Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study","volume":"105","author":"Dumeaux","year":"2003","journal-title":"Int J Cancer"},{"issue":"4","key":"R52-20230817","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","article-title":"Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"1","key":"R53-20230817","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10549-015-3663-1","article-title":"Progestin and breast cancer risk: a systematic review","volume":"155","author":"Samson","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"R54-20230817","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bjc.6603618","article-title":"Oral progestagens before menopause and breast cancer risk","volume":"96","author":"Fabre","year":"2007","journal-title":"Br J Cancer"},{"issue":"4","key":"R55-20230817","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"5","key":"R56-20230817","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.contraception.2003.12.015","article-title":"Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer","volume":"69","author":"Strom","year":"2004","journal-title":"Contraception"},{"issue":"1","key":"R57-20230817","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","article-title":"Cancer risk associated with germline DNA mismatch repair gene mutations","volume":"6","author":"Dunlop","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"8","key":"R58-20230817","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1158\/1940-6207.CAPR-13-0020","article-title":"Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus Depo-Provera for prevention of endometrial cancer in women with Lynch syndrome","volume":"6","author":"Lu","year":"2013","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000586384.47435.31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T01:11:23Z","timestamp":1692321083000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000586384.47435.31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000586384.47435.31","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}